The jump from placebo to 1mg represents GLP-1 and partial GIP activation
GLP-1 Products have achieved massive growth: By the end of 2024, these GLP-1 products had a cumulative $71 billion in U.S
Dosage: In human sleep studies, researchers have used intravenous doses of 25nmol per kilogram.13 14 Intravenous administration boasts higher bioavailability than, say, the subcutaneous route,28 which is the more common mode of administration for peptides, so a home-use case would likely involve a higher dose
It is made by Eli Lilly and can be taken as a once-daily pill at any time of day, with or without food
These are subcutaneous injections into the fat under the skin, not muscle
You have it take a tablet every day, rather than an injection once a week